Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-3.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Cash & Current Investments (2017 - 2026)

Updated

Mereo BioPharma (MREO) recorded Cash & Current Investments of $30.12 million in Q2 2026, down 46.3% from $56.13 million a year earlier but up 0.1% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Mereo BioPharma reported Cash & Current Investments of $40.99 million, down 41.3% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $69.8 million in FY2024 (+21.6%), $57.42 million in FY2023 (-13.1%), $66.08 million in FY2022 (-48.0%) and $127.11 million in FY2021 (+310.2%).
  • Quarterly Cash & Current Investments has ranged from $30.1 million in Q1 2026 to $127.11 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has declined for five consecutive quarters, with an average decline of 23.6% over the last seven quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 310.2% in Q4 2021, against a decline of 51.8% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $30.1 million (Q1 2026), $40.99 million (Q4 2025) and $48.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Mereo BioPharma 44.71 Mn -105.20 Mn - 30.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.12 Mn
Mar 31, 2026 30.10 Mn
Dec 31, 2025 40.99 Mn
Sep 30, 2025 48.70 Mn
Jun 30, 2025 56.13 Mn
Mar 31, 2025 62.50 Mn
Dec 31, 2024 69.80 Mn
Sep 30, 2024 80.52 Mn
Jun 30, 2024 87.43 Mn
Mar 31, 2024 48.70 Mn
Dec 31, 2023 57.42 Mn
Jun 30, 2023 53.12 Mn
Dec 31, 2022 67.92 Mn
Jun 30, 2022 92.71 Mn
Dec 31, 2021 127.28 Mn
Jun 30, 2021 152.40 Mn
Dec 31, 2020 31.99 Mn
Jun 30, 2020 69.95 Mn
Dec 31, 2019 21.44 Mn
Jun 30, 2019 35.86 Mn
API Access

Mereo BioPharma Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MREO&period=max&api_key=YOUR_API_KEY